Concepedia

Publication | Open Access

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

DOIFull Paper Access

874

Citations

23

References

2011

Year

Walter Reinisch, William J. Sandborn, Daniël W. Hommes, G. D’Haens, Stephen B. Hanauer, Stefanie Schreiber, Remo Panaccione, Richard N. Fedorak, M. B. Tighe, B Huang,
Gut

Abstract

ADA160/80 was safe and effective for induction of clinical remission in patients with moderately to severely active ulcerative colitis failing treatment with corticosteroids and/or immunosuppressants. Clinical trial NCT00385736.

References

YearCitations

Page 1